Home
Our Team
The Challenge
The Innovation
News
Contact & Service
News
Valencia 2023
License contract signed
CureDiab at the 6th Global NASH Congress
alytas therapeutics collaborates with CureDiab
New shareholder structure
Data about hepatoprotective activity of the positive allosteric GABAA-receptor modulator in lipotoxicity-induced injury published!